NDC Pharmacologic Class N0000000194 Somatostatin Receptor Agonists [MoA]

  1. Home
  2. NDC Pharmacologic Class Index
  3. N0000000194
NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0078-0180Sandostatin Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0181Sandostatin Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0182Sandostatin Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0633Signifor PasireotideInjectionSubcutaneousNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0634Signifor PasireotideInjectionSubcutaneousNovartis Pharmaceuticals CorporationHuman Prescription Drug
0078-0635Signifor PasireotideInjectionSubcutaneousNovartis Pharmaceuticals CorporationHuman Prescription Drug
0641-6174Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousWest-ward Pharmaceuticals Corp.Human Prescription Drug
0641-6175Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousWest-ward Pharmaceuticals Corp.Human Prescription Drug
0641-6176Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousWest-ward Pharmaceuticals Corp.Human Prescription Drug
0641-6177Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousWest-ward Pharmaceuticals Corp.Human Prescription Drug
0641-6178Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousWest-ward Pharmaceuticals Corp.Human Prescription Drug
0703-3301Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousTeva Parenteral Medicines, Inc.Human Prescription Drug
0703-3311Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousTeva Parenteral Medicines, Inc.Human Prescription Drug
0703-3321Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousTeva Parenteral Medicines, Inc.Human Prescription Drug
0703-3333Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousTeva Parenteral Medicines, Inc.Human Prescription Drug
0703-3343Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousTeva Parenteral Medicines, Inc.Human Prescription Drug
15054-1060Somatuline Depot Lanreotide AcetateInjectionSubcutaneousIpsen Biopharmaceuticals, Inc.Human Prescription Drug
15054-1090Somatuline Depot Lanreotide AcetateInjectionSubcutaneousIpsen Biopharmaceuticals, Inc.Human Prescription Drug
15054-1120Somatuline Depot Lanreotide AcetateInjectionSubcutaneousIpsen Biopharmaceuticals, Inc.Human Prescription Drug
23155-685Octreotide Acetate Octreotide AcetateInjectionIntravenousHeritage Pharmaceuticals Inc.Human Prescription Drug
23155-686Octreotide Acetate Octreotide AcetateInjectionIntravenousHeritage Pharmaceuticals Inc.Human Prescription Drug
25021-451Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsHuman Prescription Drug
25021-452Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsHuman Prescription Drug
25021-453Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsHuman Prescription Drug
25021-454Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsHuman Prescription Drug
25021-455Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousSagent PharmaceuticalsHuman Prescription Drug
55292-131Signifor PasireotideInjectionSubcutaneousRecordati Rare Diseases, Inc.Human Prescription Drug
55292-132Signifor PasireotideInjectionSubcutaneousRecordati Rare Diseases, Inc.Human Prescription Drug
55292-133Signifor PasireotideInjectionSubcutaneousRecordati Rare Diseases, Inc.Human Prescription Drug
63323-365Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcHuman Prescription Drug
63323-376Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcHuman Prescription Drug
63323-377Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcHuman Prescription Drug
63323-378Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcHuman Prescription Drug
63323-379Octreotide Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousFresenius Kabi Usa, LlcHuman Prescription Drug
67457-239Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousMylan Institutional LlcHuman Prescription Drug
67457-245Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousMylan Institutional LlcHuman Prescription Drug
67457-246Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousMylan Institutional LlcHuman Prescription Drug
76135-009Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousUsv North America Inc.Human Prescription Drug
76135-010Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousUsv North America Inc.Human Prescription Drug
76135-011Octreotide Acetate Octreotide AcetateInjection, SolutionIntravenous; SubcutaneousUsv North America Inc.Human Prescription Drug

There are 40 NDC products with the pharmacologic class Somatostatin Receptor Agonists [MoA].